Abstract: Provided are a method for automatically generating a logical topology diagram, a device and a medium. The method includes steps described below. Physical world data of a target building is acquired, where the physical world data includes at least complete relationship representation information of spaces, systems and devices in the target building; a target relationship diagram template and a target device template are determined from pre-built candidate relationship diagram templates and pre-built candidate device templates according to the physical world data and a topology diagram generation requirement; and a target logical topology diagram corresponding to the topology diagram generation requirement is generated according to the target relationship diagram template and the target device template based on the complete relationship representation information in the physical world data.

Abstract: Provided are a method for processing graphic elements in a logical topology diagram and a device.

Abstract: Provided are a method for generating an attachment in a logical topology diagram and a device. The method includes the steps described below. Physical world data of a target building is acquired, and a target relationship diagram template is determined from pre-built candidate relationship diagram templates according to the physical world data and a topology diagram generation requirement; connecting line information of a graphic element in the logical topology diagram is determined according to the target relationship diagram template; and attachment information in the logical topology diagram is generated according to template attachment information in the target relationship diagram template and the connecting line information of the graphic elements.

Abstract: An asparagine-linked glycan (N-glycan) detection reagent is provided that utilizes Fbs variants engineered from mouse Fbs proteins, wherein the Fbs variants bind specifically to N-glycosylated peptides and proteins and not to non-glycosylated peptides and proteins, including wherein the Fbs variants bind to N-glycosylated peptides and proteins and not to corresponding non-glycosylated versions of the same peptides and proteins. Compositions and methods for developing and using N-glycosylation-specific analytical, diagnostic, and therapeutic tools are provided.